Haemonetics Appoints New CFO, Restructures Key Roles
Ticker: HAE · Form: 8-K · Filed: Sep 16, 2024 · CIK: 313143
| Field | Detail |
|---|---|
| Company | Haemonetics Corp (HAE) |
| Form Type | 8-K |
| Filed Date | Sep 16, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, personnel
TL;DR
Haemonetics names new CFO, Brian J. Smith, effective Sept 16. Brenda Foster moves to Strategic Initiatives.
AI Summary
Haemonetics Corp. announced on September 10, 2024, changes in its executive team. The company appointed Brian J. Smith as Chief Financial Officer and Executive Vice President, effective September 16, 2024. Concurrently, Brenda L. Foster will transition from CFO to Executive Vice President, Strategic Initiatives, and will also serve as interim General Counsel.
Why It Matters
This executive reshuffling signals a strategic shift within Haemonetics, potentially impacting financial strategy and legal oversight.
Risk Assessment
Risk Level: medium — Changes in key executive positions, especially the CFO, can introduce uncertainty regarding future financial strategies and operational execution.
Key Players & Entities
- Haemonetics Corp. (company) — Registrant
- Brian J. Smith (person) — Appointed Chief Financial Officer and Executive Vice President
- Brenda L. Foster (person) — Transitioning from CFO to Executive Vice President, Strategic Initiatives and interim General Counsel
- September 10, 2024 (date) — Date of Report
- September 16, 2024 (date) — Effective date for new CFO
FAQ
What is the effective date for Brian J. Smith's appointment as CFO?
Brian J. Smith's appointment as Chief Financial Officer and Executive Vice President is effective September 16, 2024.
What new role will Brenda L. Foster assume?
Brenda L. Foster will transition from CFO to Executive Vice President, Strategic Initiatives, and will also serve as interim General Counsel.
What is Haemonetics Corporation's state of incorporation?
Haemonetics Corporation is incorporated in Massachusetts.
What is the company's principal executive office address?
The principal executive offices are located at 125 Summer Street, Boston, MA 02110.
What is the SIC code for Haemonetics Corp.?
The Standard Industrial Classification (SIC) code for Haemonetics Corp. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 426 words · 2 min read · ~1 pages · Grade level 11.9 · Accepted 2024-09-16 16:17:28
Filing Documents
- hae-20240910.htm (8-K) — 23KB
- 0000313143-24-000056.txt ( ) — 143KB
- hae-20240910.xsd (EX-101.SCH) — 2KB
- hae-20240910_lab.xml (EX-101.LAB) — 21KB
- hae-20240910_pre.xml (EX-101.PRE) — 12KB
- hae-20240910_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HAEMONETICS CORPORATION September 16, 2024 By: /s/ Christopher A. Simon Name: Christopher A. Simon Title: President and Chief Executive Officer